Scivita Medical Technology Co., Ltd., a Hong Kong-based maker of endoscopy products, received nearly RMB0.4 Billion in Series B financing.
Backers included new investors such as Hudson Bay Capital Management and Prime Capital, as well as existing shareholders such as GL Ventures, Lilly Asia Ventures and Matrix Partners China.
The company intends to use the funds for research and development, capacity expansion, and domestic and international commercialization of innovative products in endoscopy and related fields.
Scivita Medical offers products including 3D Visualization System, 4K UHD Camera System, 4K-3D Camera System, 4K Sinoscope, 4K Arthroscope, single-use Hystero Videoscope, single-use Urology Videoscope, single-use Broncho Videoscope, etc. In the future, the company will continue to launch new products while promoting the simultaneous certification of related products in China, the United States, Japan, Europe and other countries and regions, and continue to promote the products to the global market.
Since its inception, Scivita Medical has taken globalization as an important strategy and has set up R&D centres in Suzhou, China and Tokyo, Japan to promote simultaneous global R&D, patent application, registration and commercialization of its products, and aims to build a global platform for innovative products in endoscopy and related fields.